Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback